Review



selective a2bar antagonist psb1115  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Tocris selective a2bar antagonist psb1115
    Selective A2bar Antagonist Psb1115, supplied by Tocris, used in various techniques. Bioz Stars score: 99/100, based on 543 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bar+antagonist+psb1115/PSB+1115/pm29898376-154-17-24
    Average 99 stars, based on 543 article reviews
    selective a2bar antagonist psb1115 - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Concentration Assay:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Enzyme-linked Immunosorbent Assay:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    MPO Assay:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Activity Assay:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Control:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Staining:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Isolation:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Quantitative RT-PCR:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Gene Expression:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Real-time Polymerase Chain Reaction:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Expressing:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    SDS Page:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Western Blot:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).

    Clinical Proteomics:

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10 –3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10 –7 M, 300 μl intratracheally; Tocris); or vehicle ( 13 ).

    Article Title: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice
    Article Snippet: In subsets of experiments, mice were treated with the A2BAR antagonist PSB1115 (10 mg/kg i.p.; Tocris) or the A2BAR agonist BAY 60-6583 (2 mg/kg i.p.; Bayer Healthcare), the A1AR antagonist DPCPX (1 mg/kg i.p.; Tocris), the A3AR antagonist MRS1191 (1 mg/kg i.p.; Sigma-Aldrich), amiloride (10–3 M, 300 μl intratracheally; Sigma-Aldrich), or zinterol (10–7 M, 300 μl intratracheally; Tocris); or vehicle (13).



    Similar Products

    a2bar antagonist psb1115  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology a2bar antagonist psb1115
    A2bar Antagonist Psb1115, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bar+antagonist+psb1115/PSB+1115/pmc07253199-193-8-11
    Average 90 stars, based on 1 article reviews
    a2bar antagonist psb1115 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    a2bar antagonist psb1115  (R&D Systems)
    99
    R&D Systems a2bar antagonist psb1115
    A2bar Antagonist Psb1115, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bar+antagonist+psb1115/PSB+1115/pm30952101-68-1-6
    Average 99 stars, based on 1 article reviews
    a2bar antagonist psb1115 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    selective a2bar antagonist psb1115  (Tocris)
    99
    Tocris selective a2bar antagonist psb1115
    Selective A2bar Antagonist Psb1115, supplied by Tocris, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bar+antagonist+psb1115/PSB+1115/pm29898376-154-17-24
    Average 99 stars, based on 1 article reviews
    selective a2bar antagonist psb1115 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    a2bar antagonist psb1115  (Tocris)
    93
    Tocris a2bar antagonist psb1115
    A2bar Antagonist Psb1115, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2bar+antagonist+psb1115/PSB+1115/pmc02532979-566-9-15
    Average 93 stars, based on 1 article reviews
    a2bar antagonist psb1115 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results